Cargando…
Partial Identification of Amyloid-β Degrading Activity in Human Serum
The major hallmarks of Alzheimer’s disease (AD) are the extracellular accumulation of pathological amyloid beta (Aβ) in the brain parenchyma and Aβ deposition in cerebral blood walls (cerebral amyloid angiopathy; CAA). Although CAA occurs in more than 80% of AD patients, the mechanisms of Aβ deposit...
Autores principales: | Mikawa, Ryuta, Okuno, Alato, Yoshimi, Tatsuya, Watanabe, Atsushi, Maruyama, Mitsuo, Takikawa, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nagoya University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6433627/ https://www.ncbi.nlm.nih.gov/pubmed/30962655 http://dx.doi.org/10.18999/nagjms.81.1.55 |
Ejemplares similares
-
Lipidomic analysis of brain tissues and plasma in a mouse model expressing mutated human amyloid precursor protein/tau for Alzheimer’s disease
por: Tajima, Yoko, et al.
Publicado: (2013) -
NMR-based metabolomics of urine in a mouse model of Alzheimer’s disease: identification of oxidative stress biomarkers
por: Fukuhara, Kiyoshi, et al.
Publicado: (2013) -
Dietary Hesperidin Suppresses Lipopolysaccharide-Induced Inflammation
in Male Mice
por: Sato, Mizuho, et al.
Publicado: (2022) -
β-Amyloid Degradation and Alzheimer's Disease
por: Wang, Deng-Shun, et al.
Publicado: (2006) -
Differential Effect of Non-Purified and Semi-Purified Standard Diets on Kynurenine and Peripheral Metabolites in Male C57BL/6J Mice
por: Yajima, Yuhei, et al.
Publicado: (2022)